These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1332571)

  • 1. Pyrophosphate in synovial fluid and urine and its relationship to urinary risk factors for stone disease.
    Roberts NB; Dutton J; Helliwell T; Rothwell PJ; Kavanagh JP
    Ann Clin Biochem; 1992 Sep; 29 ( Pt 5)():529-34. PubMed ID: 1332571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synovial fluid pyrophosphate and nucleoside triphosphate pyrophosphatase: comparison between normal and diseased and between inflamed and non-inflamed joints.
    Pattrick M; Hamilton E; Hornby J; Doherty M
    Ann Rheum Dis; 1991 Apr; 50(4):214-8. PubMed ID: 1851409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary pyrophosphate in patients with recurrent calcium urolithiasis and in healthy controls: a re-evaluation.
    Schwille PO; Rümenapf G; Wölfel G; Köhler R
    J Urol; 1988 Aug; 140(2):239-45. PubMed ID: 2840520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of inorganic pyrophosphate by normal subjects and patients with renal calculi in north-western India and the effect of diclofenac sodium upon urinary excretion of pyrophosphate in stone formers.
    Sharma S; Vaidyanathan S; Thind SK; Nath R
    Urol Int; 1992; 48(4):404-8. PubMed ID: 1329300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inorganic pyrophosphate in metabolic diseases predisposing to calcium pyrophosphate dihydrate crystal deposition.
    Doherty M; Chuck A; Hosking D; Hamilton E
    Arthritis Rheum; 1991 Oct; 34(10):1297-303. PubMed ID: 1657004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical studies in paraplegic renal stone patients. 2. Urinary excretion of citrate, inorganic pyrophosphate, silicate and urate.
    Burr RG; Nuseibeh I; Abiaka CD
    Br J Urol; 1985 Jun; 57(3):275-8. PubMed ID: 2988686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-control study of risk factors for idiopathic calcium nephrolithiasis.
    Wasserstein AG; Stolley PD; Soper KA; Goldfarb S; Maislin G; Agus Z
    Miner Electrolyte Metab; 1987; 13(2):85-95. PubMed ID: 3696092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypophosphatasia: biochemical screening of a Dutch kindred and evidence that urinary excretion of inorganic pyrophosphate is a marker for the disease.
    Macfarlane JD; Poorthuis BJ; van de Kamp JJ; Russell RG; Caswell AM
    Clin Chem; 1988 Sep; 34(9):1937-41. PubMed ID: 2843309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers.
    Eisner BH; Porten SP; Bechis SK; Stoller ML
    J Urol; 2010 Jun; 183(6):2244-8. PubMed ID: 20400141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inorganic pyrophosphate pool size and turnover rate in arthritic joints.
    Camerlain M; McCarty DJ; Silcox DC; Jung A
    J Clin Invest; 1975 Jun; 55(6):1373-81. PubMed ID: 166095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
    Curhan GC; Willett WC; Speizer FE; Stampfer MJ
    Kidney Int; 2001 Jun; 59(6):2290-8. PubMed ID: 11380833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine volume and its effects on renal stone risk in astronauts.
    Whitson PA; Pietrzyk RA; Sams CF
    Aviat Space Environ Med; 2001 Apr; 72(4):368-72. PubMed ID: 11318017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acute acid loading on acid-base and calcium metabolism.
    Osther PJ
    Scand J Urol Nephrol; 2006; 40(1):35-44. PubMed ID: 16452054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.